Research Frontiers Stock (NASDAQ:REFR), Trade Ideas

Research Frontiers

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADAP

AEVA

AIMD

AIRE

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

AQST

ASLE

BBAI

BREA

CERO

COOK

COST

CRML

CRMT

CTOS

DOGZ

DOMO

EGOX

GIFI

GRFS

GROM

IMRN

JYNT

MIRA

MOBX

MRVL

PRCH

PRTS

RDFN

RDNT

REFR

RWAY

SWBI

SWVL

VIRX

WLDN

Shares of  Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Long Ideas

Insider Trades

Pre-Market Outlook

DBVT

DFCO

The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

DBV Technologies And 2 Other Stocks Under $2 Insiders Are Buying

FBRX

SDOT

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying

Research Frontiers Incorporated - Common Stock

Research Frontiers Inc

<h3>Gainers</h3>
<ul>
<li>Intellicheck (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDN#NASDAQ">IDN</a>) shares increased by 31.6% to $4.03 during Monday's regular session. The market value of their outstanding shares is at $77.9 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Cleanspark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares moved upwards by 21.87% to $23.79. The company's market cap stands at $4.7 billion. </li>
<li>Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) stock increased by 21.03% to $1.52. The company's market cap stands at $51.1 million. </li>
<li>MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares moved upwards by 20.81% to $1840.06. The company's market cap stands at $31.2 billion. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock moved upwards by 18.46% to $1.54. The company's market cap stands at $24.1 million. As per the press release, Q4 earnings came out 2 days ago. </li>
<li>Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) stock increased by 14.58% to $80.21. The market value of their outstanding shares is at $12.2 billion. The company's, Q2 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) shares fell 27.0% to $10.7 during Monday's regular session. The company's market cap stands at $308.6 million. </li>
<li>Rubicon Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBT#NYSE">RBT</a>) shares declined by 19.51% to $0.41. The company's market cap stands at $17.5 million. </li>
<li>Formula Sys (1985) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORTY#NASDAQ">FORTY</a>) shares declined by 17.28% to $68.67. The company's market cap stands at $1.0 billion. As per the news, the Q4 earnings report came out 4 days ago. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares decreased by 10.01% to $3.15. The market value of their outstanding shares is at $18.8 million. </li>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) stock fell 9.88% to $1.46. The market value of their outstanding shares is at $32.7 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock fell 9.78% to $2.03. The company's market cap stands at $404.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHR

ALAB

BTCS

CLSK

FORTY

LAES

MSTR

12 Information Technology Stocks Moving In Monday's Intraday Session

Shares of Marvell Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrvl#NASDAQ">MRVL</a>) fell sharply during Friday&rsquo;s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
Marvell said fourth-quarter revenue increased 1% year-over-year to $1.427 billion, which beat the consensus estimate of $1.42 billion. The chip designer reported quarterly earnings of 46 cents per share, which was in line with analyst estimates.
Marvell sees first-quarter revenue of $1.15 billion, plus or minus 5%, versus estimates of $1.371 billion. The company sees first-quarter adjusted earnings of 23 cents per share, plus or minus 5 cents per share, versus estimates of 40 cents per share. The company authorized a $3 billion buyback.
Marvell Technology shares dipped 9.6% to $76.91 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) jumped 140% to $2.6899 after dipping 18% on Thursday.
Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) shares climbed 139% to $3.0350. Psyence Biomedical recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares jumped 138% to $1.57 after the company announced financing for the Norman Berry Expansion in Atlanta, Georgia.
MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) shares climbed 48.5% to $1.36. MIRA Pharmaceuticals, last month, announced a research collaboration with Pharmaseed to research and evaluate Ketamir for patients with major depressive disorder and post-traumatic stress disorder.
CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) shares climbed 35.4% to $4.17 after surging over 20% on Thursday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
Willdan Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wldn#NASDAQ">WLDN</a>) gained 30.4% to $25.89 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance above estimates. Also, the company secured a contract worth approximately $30 million to $50 million over three years.
The Joint Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jynt#NASDAQ">JYNT</a>) gained 29% to $11.80 following fourth-quarter results.
Smith &amp; Wesson Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swbi#NASDAQ">SWBI</a>) jumped 25.8% to $16.91 after the company reported better-than-expected third-quarter financial results.
Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) climbed 25.6% to $1.42 following fourth-quarter results.
Gulf Island Fabrication, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gifi#NASDAQ">GIFI</a>) shares gained 24.1% to $6.43 after the company reported a year-over-year increase in fourth-quarter revenue results.
Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) gained 22.7% to $6.89 after the company announced it published its consolidated annual accounts for 2023.
DoubleDown Interactive Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ddi#NASDAQ">DDI</a>) gained 21.6% to $14.25.
Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 18.6% to $7.98.
Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 18.3% to $3.0177.
America&#39;s Car-Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crmt#NASDAQ">CRMT</a>) jumped 16.5% to $72.56 following third-quarter results.
Porch Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prch#NASDAQ">PRCH</a>) rose 16.1% to $3.6099 after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance.
Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) gained 14.3% to $39.28 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates.
Viracta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virx#NASDAQ">VIRX</a>) shares gained 13.5% to $0.9200 following fourth-quarter results.
Aeva Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeva#NASDAQ">AEVA</a>) rose 12.6% to $1.34.
Adaptimmune Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adap#NASDAQ">ADAP</a>) gained 12.1% to $1.95. Adaptimmune Therapeutics recently reported better-than-expected quarterly EPS results.
HCI Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hci#NYSE">HCI</a>) gained 11.3% to $110.42 after the company reported better-than-expected fourth-quarter financial results.
NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) jumped 10.5% to $4.9289.
Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) jumped 9.6% to $7.10.
reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) rose 8.8% to $1.3599. reAlpha Tech, last month, appointed Michael Frenz as CFO and Mike Logozzo as President and COO.
Carnival Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ccl#NYSE">CCL</a>) gained 5% to $16.44.
<h3>Losers</h3>
Amylyx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amlx#NASDAQ">AMLX</a>) shares fell 80.7% to $3.6596 after the company announced its PHOENIX phase 3 trial of AMX0035 for amyotrophic lateral sclerosis did not meet its primary endpoint and there was no statistical significance seen in secondary endpoints.
BigBear.ai Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bbai#NYSE">BBAI</a>) fell 30.8% to $2.6006 after the company reported worse-than-expected fourth-quarter financial results.
Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) tumbled 28.6% to $0.0819.
Critical Metals Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crml#NASDAQ">CRML</a>) fell 27.7% to $7.95.
Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 26.3% to $5.45.
Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares dipped 24.7% to $3.4250 after jumping 161% on Thursday.
AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) fell 24.4% to $7.11 after the company reported worse-than-expected fourth-quarter financial results.
CarParts.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prts#NASDAQ">PRTS</a>) fell 24.3% to $1.8999 following fourth-quarter results.
Mobix Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobx#NASDAQ">MOBX</a>) fell 20.1% to $1.39.
Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) fell 19% to $0.8001 after surging 28% on Thursday. Nxu recently announced it successfully charged a Tesla Cybertruck.
Brera Holdings PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brea#NASDAQ">BREA</a>) shares fell 16.9% to $1.62. Brera Holdings shares jumped 91% on Thursday after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company. 
Custom Truck One Source, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctos#NYSE">CTOS</a>) dipped 15.3% to $5.26 after the company reported mixed quarterly financial results.
Nexalin Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxl#NASDAQ">NXL</a>) fell 15.1% to $0.4627. Nexalin Technology recently announced results of a clinical study of its Gen-2 tACS device for the treatment of chronic insomnia.
Runway Growth Finance Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rway#NASDAQ">RWAY</a>) fell 13.5% to $11.68 following downbeat quarterly results.
Domo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/domo#NASDAQ">DOMO</a>) fell 12.7% to $9.92 after the company issued soft first-quarter and FY25 guidance.
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) declined 12.4% to $19.05 after the company announced a secondary offering of 3 million shares.
Genesco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gco#NYSE">GCO</a>) fell 11.7% to $25.84 after the company&#39;s reported a fourth-quarter EPS miss and issued weak FY25 guidance.
Delek Logistics Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dkl#NYSE">DKL</a>) fell 11.3% to $39.51 after the company priced a public offering of 3,116,884 common units at $38.50 per unit.
Grom Social Enterprises, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grom#NASDAQ">GROM</a>) fell 11% to $1.13 after jumping 65% on Thursday. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.
Traeger, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cook#NYSE">COOK</a>) fell 10.5% to $2.11 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance below estimates.
Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) dipped 10% to $5.11 following fourth-quarter results.
Petr&oacute;leo Brasileiro S.A. - Petrobras (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbr#NYSE">PBR</a>) shares fell 9.6% to $15.10 as the company reported a 6.3% year-over-year decline in its fourth-quarter net recurring profit.
Costco Wholesale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cost#NASDAQ">COST</a>) fell 7.5% to $727.08 following mixed second-quarter results.
MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) declined 6.4% to $385.82 after the company issued weak FY25 guidance.
Icahn Enterprises L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iep#NASDAQ">IEP</a>) fell 4.7% to $17.85.
RadNet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdnt#NASDAQ">RDNT</a>) dipped 4.1% to $46.54. RadNet priced its public offering of 4.55 million common stock at $44 per share.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37553898/cramer-says-sprout-social-is-in-a-hot-spot-but-this-energy-stock-is-too-down-and-out"> Cramer Says Sprout Social Is In A &#39;Hot Spot,&#39; But This Energy Stock Is &#39;Too Down And Out&#39; </a>

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Earnings

AFCG

ALIM

AMTX

AOUT

ARBE

ARCT

ARHS

ASPS

AVGO

BBCP

BILI

BITF

BNED

BURL

CHMI

CIEN

CINT

CLAR

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

DLTH

DOCU

DSGR

DXPE

ELUT

EOLS

EVGN

EYPT

FCEL

FNKO

GEVO

GRND

GRNT

GWRE

HBIO

ISDR

LCTX

LMNR

LOCO

LUMO

LVRO

METC

MGNX

MKFG

NAPA

NCSM

NDLS

NEPH

NINE

ONCT

ONCY

OPFI

OPTN

OWLT

PBPB

PHAT

PMTS

PowerShares Dynamic Industrials Sector Portfolio

PROF

PSFE

RDVT

REAX

SDPI

SGHT

Earnings Scheduled For March 7, 2024

The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Dalrada Financial </h3>
<ul>
<li>The Trade: Dalrada Financial Corporation (OTC: <a class="ticker" href="https://www.benzinga.com/stock/dfco#OTC">DFCO</a>) Chief Executive Officer Brian Bonar <a href="https://www.benzinga.com/quote/DFCO/analyst-ratings"> acquired a total of 52,600 shares </a> an average price of $0.22. To acquire these shares, it cost around $11,831.</li>
<li>What&rsquo;s Happening: The company&rsquo;s stock fell around 16% over the past month.</li>
<li>What Dalrada Financial Does: Dalrada Financial Corp is a United States-based company engaged in providing financial, insurance, benefit, and business process outsourcing products and services to companies.</li>
</ul>
<h3>Research Frontiers</h3>
<ul>
<li>The Trade: Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) Director Darryl Daigle <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,000 shares at </a> at an average price of $1.00. To acquire these shares, it cost around $1,000.</li>
<li>What&rsquo;s Happening: On Nov. 2, Research Frontiers posted a narrower third-quarter loss.</li>
<li>What Research Frontiers Does: Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/02/37026817/investor-sentiment-edges-higher-as-s-p-500-briefly-breaches-5-000-level"> Investor Sentiment Edges Higher As S&amp;P 500 Briefly Breaches 5,000 Level </a>
<h3>DBV Technologies </h3>
<ul>
<li>The Trade: DBV Technologies S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbvt#NASDAQ">DBVT</a>) Director Adora Ndu <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,825 shares </a> at an average price of $0.89. The insider spent around $1,624 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 10, DBV Technologies announced 2-year results from ongoing Phase 3 open-label extension to the EPITOPE trial (EPOPEX) of Viaskin&trade; peanut in toddlers.</li>
<li>What DBV Technologies Does: DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
&nbsp;

<h3>Gainers</h3>
<ul>
<li>Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) stock increased by 5.0% to $0.25 during Friday's after-market session. The company's market cap stands at $8.5 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock increased by 4.93% to $0.45. The market value of their outstanding shares is at $8.3 million. </li>
<li>Spectaire Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) shares moved upwards by 4.73% to $1.77. The market value of their outstanding shares is at $27.1 million. </li>
<li>BTCS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCS#NASDAQ">BTCS</a>) stock increased by 4.54% to $2.3. The company's market cap stands at $33.0 million. </li>
<li>Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) shares increased by 3.6% to $1.15. The company's market cap stands at $38.5 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 3.44% to $1.8. The company's market cap stands at $11.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares fell 7.3% to $3.69 during Friday's after-market session. The market value of their outstanding shares is at $105.6 million. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) shares decreased by 5.9% to $13.08. The market value of their outstanding shares is at $199.6 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) shares decreased by 4.95% to $0.25. The company's market cap stands at $4.9 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares decreased by 4.53% to $0.78. The market value of their outstanding shares is at $8.2 million. </li>
<li>Sigma Additive Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SASI#NASDAQ">SASI</a>) shares decreased by 3.98% to $4.35. The company's market cap stands at $3.3 million. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) stock fell 3.93% to $3.67. The market value of their outstanding shares is at $5.9 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATGL

AUUD

INTZ

LIDR

SASI

SLNH

SOBR

SPEC

SVRE

12 Information Technology Stocks Moving In Friday's After-Market Session

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>OLB Group </h3>
<ul>
<li>The Trade: The OLB Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/olb#NASDAQ">OLB</a>) Chairman and CEO Ronny Yakov <a href="https://www.benzinga.com/quote/OLB/analyst-ratings"> acquired a total of 22,315 shares </a> an average price of $0.75. To acquire these shares, it cost around $16,739.</li>
<li>What&rsquo;s Happening: On Nov. 15, the company posted a wider-than-expected quarterly loss.</li>
<li>What OLB Group Does: The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise.</li>
</ul>
<h3>Research Frontiers</h3>
<ul>
<li>The Trade: Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) Director Darryl Daigle <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 7,750 shares </a> at an average price of $0.97. To acquire these shares, it cost around $7,518.</li>
<li>What&rsquo;s Happening: On Nov. 2, Research Frontiers posted a narrower third-quarter loss.</li>
<li>What Research Frontiers Does: Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/12/36190200/how-to-earn-500-a-month-from-oracle-stock-after-q2-earnings-results"> How To Earn $500 A Month From Oracle Stock After Q2 Earnings Results </a>
<h3>Sadot Group </h3>
<ul>
<li>The Trade: Sadot Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdot#NASDAQ">SDOT</a>) Director David Errington <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 10,000 shares </a> at an average price of $0.40. The insider spent around $3,986 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 14, Sadot Group posted upbeat quarterly sales.</li>
<li>What Sadot Group Does: Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region.</li>
</ul>
<h3>Forte Biosciences </h3>
<ul>
<li>The Trade: Forte Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbrx#NASDAQ">FBRX</a>) Director Paul A Wagner <a href="https://www.benzinga.com/quote/ERAS/analyst-ratings"> acquired a total of 29,776 shares </a> at an average price of $0.65. The insider spent around $19,276 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 13, Forte Biosciences posted a wider third-quarter loss.</li>
<li>What Forte Biosciences Does: Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (&quot;GvHD&quot;), vitiligo and alopecia areata (&quot;AA&quot;).</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

<h3>Gainers</h3>
<ul>
<li>DigitalOcean Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) stock rose 27.2% to $27.0 during Friday's pre-market session. The company's market cap stands at $2.3 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) shares increased by 15.7% to $1.18. The market value of their outstanding shares is at $39.5 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>CalAmp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) stock rose 14.5% to $0.26. The company's market cap stands at $10.0 million. </li>
<li>Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) stock rose 12.52% to $47.9. The market value of their outstanding shares is at $2.6 billion. As per the press release, Q3 earnings came out yesterday. </li>
<li>eGain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGAN#NASDAQ">EGAN</a>) stock increased by 12.43% to $6.78. The company's market cap stands at $212.2 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) stock moved upwards by 9.82% to $0.76. The company's market cap stands at $12.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Inseego (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) shares fell 29.5% to $0.37 during Friday's pre-market session. The company's market cap stands at $42.8 million. The company's, Q3 earnings came out yesterday. </li>
<li>BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) stock fell 26.68% to $65.6. The market value of their outstanding shares is at $7.0 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) shares decreased by 22.91% to $44.4. The market value of their outstanding shares is at $34.8 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Ubiquiti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UI#NYSE">UI</a>) shares fell 10.13% to $112.0. The company's market cap stands at $6.7 billion. </li>
<li>WaveDancer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVD#NASDAQ">WAVD</a>) shares fell 8.33% to $1.48. The market value of their outstanding shares is at $2.8 million. </li>
<li>My Size (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYSZ#NASDAQ">MYSZ</a>) stock declined by 7.02% to $0.9. The market value of their outstanding shares is at $4.0 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BILL

CAMP

DOCN

EGAN

FTNT

INSG

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MYSZ

WAVD

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) reported quarterly losses of $(0.01) per share. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported $164.15 thousand in sales this quarter. This is a 9.11 percent increase over sales of $150.44 thousand the same period last year.

Research Frontiers Q3 EPS $(0.01) Up From $(0.02) YoY, Sales $164.15K Up From $150.44K YoY